Neuphoria Therapeutics Inc. - Common Stock

Share · US64136E1029 · NEUP (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

05.11.2025 00:31

Current Prices from Neuphoria Therapeutics Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	NEUP	USD	05.11.2025 00:31	4,15 USD	-0,07 USD -1,66 %

Share Float & Liquidity

Free Float 95,30 %

Shares Float 1,79 M

Shares Outstanding 1,88 M

Company Profile for Neuphoria Therapeutics Inc. - Common Stock Share

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Get up to date insights from finAgent about Neuphoria Therapeutics Inc. - Common Stock

Company Data

Name Neuphoria Therapeutics Inc. - Common Stock

Company Neuphoria Therapeutics Inc.

Symbol NEUP

Website http://www.neuphoriatx.com

Primary Exchange

NASDAQ

ISIN US64136E1029

Asset Class Share

Sector Healthcare

Industry Medical - Pharmaceuticals

CEO Spyridon Papapetropoulos

Country United States of America

Currency USD

Employees 0,0 T

Address 100 Summit Dr, Burlington

IPO Date 2021-12-16

ID Changes

Date	From	To
24.12.2024	BNOX	NEUP

Ticker Symbols

Name	Symbol
NASDAQ	NEUP

More Shares

Investors who hold Neuphoria Therapeutics Inc. - Common Stock also have the following shares in their portfolio:

EMPOWER CLINICS INC Share

Fidelity Income Fund - Fidelity Simplicity RMD 2015 Fund Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog